Home » Topics » BioWorld Science

BioWorld Science
RSS

JM-473 candidate for clinical development

March 15, 1996

Novel platinum compound reported

March 15, 1996

AllerVax codevelopment terminated by HMR

March 15, 1996

AI-502 slated to enter clinical trials

March 15, 1996

Axis Genetics reports on vaccine technology

March 15, 1996

T Cell Sciences, ArQule to collaborate on T cell modulators

March 15, 1996

Colloral dose refinement study underway

March 15, 1996

Lilly reports drugs for osteoarthritis

March 15, 1996

Glaxo Wellcome formalizes development status of arthritis drug

March 15, 1996

U.S. phase III trials of Remune begin

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...